Frank P. Vendetti - Concepedia

Author

Frank P. Vendetti

University of Pittsburgh

Also Known As

F. Vendetti, F.P. Vendetti, Farrukh Hammed, Frank P Vendetti, Frank P. Vendetti, Frank Vendetti, Sheryl Kunning

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh UPMC Hillman Cancer Center Johns Hopkins University AstraZeneca (United Kingdom)Memorial Sloan Kettering Cancer Center

About

Frank P. Vendetti is an author at University of Pittsburgh specializing in medicine, tumor biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	143
2	Cell Biology	3	3	120
3	Health Sciences	1	1	10
4	Natural Sciences	1	1	69
5	Cellular Physiology	1	1	69

Frank P. Vendetti

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer Rosalyn A. Juergens, John Wrangle, Frank P. Vendetti, Cancer Discovery	2011	668
Alterations of immune response of non-small cell lung cancer with Azacytidine John Wrangle, Wei Wang, Alexander Koch, Oncotarget	2013	382
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer<i>in vivo</i> Frank P. Vendetti, Alan Lau, Sandra Schamus, Oncotarget	2015	235
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation Frank P. Vendetti, Pooja Karukonda, David A. Clump, Journal of Clinical Investigation	2018	202
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell Lulu Shao, Weizhou Hou, Nicole E. Scharping, Cancer Immunology Research	2019	83
Differential Actin-dependent Localization Modulates the Evolutionarily Conserved Activity of Shroom Family Proteins Megan L. Dietz, Teresa M. Bernaciak, Frank P. Vendetti, Journal of Biological Chemistry Molecular BiologyShroom Family ProteinsCytoskeletonCellular PhysiologyProtein Folding	2006	69
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy Frank P. Vendetti, Pinakin Pandya, David A. Clump, JCI Insight Atr Inhibitor Azd6738ImmunologyImmunoeditingImmunotherapeuticsImmune Cell Therapy	2023	31
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer Frank P. Vendetti, Michael J. Topper, Peng Huang, Oncotarget	2014	30
Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression Norie Sugitani, Frank P. Vendetti, Andrew J. Cipriano, Cell Reports	2022	23
Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation Frank P. Vendetti, Brian J. Leibowitz, Jennifer Barnes, Scientific Reports	2017	20

Page 1